標題: 日股..製藥..Shionogi 塩野義製薬(日股 4507,美股 SGIOY,SGIOF)
kaka
同學




UID 6717
精華 0
積分 0
帖子 6266
閱讀權限 99
註冊 2014-5-7
用戶註冊天數 3613
用戶失蹤天數 1720

111.83.18.104
分享 
發表於 2017-11-5 17:07  資料 私人訊息 
日股..製藥..Shionogi 塩野義製薬(日股 4507,美股 SGIOY,SGIOF)
日股..製藥..Shionogi 塩野義製薬株式会社(日股 4507,美股 SGIOY,SGIOF)

日經225指數成分股
http://www.investor.com.tw/nfastnews/ADgif/AD_content/060227_09/0227_09n225-01.htm

http://www.shionogi.co.jp

https://en.wikipedia.org/wiki/Shionogi

Shionogi & Company, Limited (塩野義製薬株式会社, Shionogi Seiyaku Kabushiki Kaisha) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses Shionogi ("Ёレвヰ").

Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines.

In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan.

Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV.[3]

The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index.[4]

頂部